Compare PRI & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRI | BAX |
|---|---|---|
| Founded | 1927 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3B | 9.4B |
| IPO Year | N/A | N/A |
| Metric | PRI | BAX |
|---|---|---|
| Price | $253.13 | $18.38 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 10 |
| Target Price | ★ $303.40 | $25.67 |
| AVG Volume (30 Days) | 196.6K | ★ 8.5M |
| Earning Date | 11-05-2025 | 10-30-2025 |
| Dividend Yield | ★ 1.65% | 0.21% |
| EPS Growth | ★ 65.97 | N/A |
| EPS | ★ 21.75 | N/A |
| Revenue | $3,335,204,000.00 | ★ $11,023,000,000.00 |
| Revenue This Year | $4.61 | $5.20 |
| Revenue Next Year | $5.79 | $2.02 |
| P/E Ratio | $11.62 | ★ N/A |
| Revenue Growth | ★ 10.41 | 3.90 |
| 52 Week Low | $230.98 | $17.40 |
| 52 Week High | $301.85 | $37.74 |
| Indicator | PRI | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 41.72 | 41.54 |
| Support Level | $251.62 | $18.54 |
| Resistance Level | $260.44 | $19.17 |
| Average True Range (ATR) | 5.50 | 0.54 |
| MACD | -0.06 | 0.23 |
| Stochastic Oscillator | 8.16 | 53.76 |
Primerica Inc is a provider of financial services to middle-income households in the United States and Canada. The company offers life insurance, mutual funds, annuities, and other financial products, distributed on behalf of third parties. Primerica has three main subsidiaries: Primerica Financial Services, a marketing company; Primerica Life Insurance Company, a principal life insurance underwriting entity; and PFS Investments, which offers investment and savings products, brokerage services, and registered investment advisory. It has three segments Term Life Insurance; Investment and Savings Products; and Corporate and Other Distributed Products. Geogriphically, it derives a majority of its revenue from the United States.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.